Join the CannMed Legalization Panel
Sunday, May 12th, Marco Island, FL
In 2023, the HHS took a monumental step in recommending reclassifying cannabis from Schedule I to Schedule III, signaling a potential shift in federal regulation. As we move through 2024 the landscape of cannabis reform extends beyond rescheduling, with a surge in congressional support evident from over a dozen filed bills.
Image
Image
Image

Program Overview

Join our expert panel of scientists, legal professionals, cannabis industry executives for an insightful discussion on the economic prospects, research considerations, and regulatory frameworks in the evolving cannabis legalization landscape. Prepare for the expanded horizons of cannabis policy in this thought-provoking exploration of the future.

Capital Markets Participants

Headshot of David Traylor

David Traylor
Senior Managing Director

Golden Eagle Partners
VIEW BIO

Headshot of Matt Daugherty

Matt Daugherty
Senior Vice President
Golden Eagle Partners

Headshot of Charles Farkas

Charles Farkas
Chairman of The Board
Medicinal Genomics
VIEW BIO

Headshot of Kevin McKernan

Kevin McKernan
Chief Scientific Officer
Medicinal Genomics
VIEW BIO

Headshot of Oliver Cruze

David Meiri, PhD
Laboratory of Cancer Biology & Cannabinoid Research - Technion
VIEW BIO

Headshot of Ethan Russo

Ethan Russo, MD
Founder/CEO

CReDO Science
VIEW BIO

Headshot of Debra Kimless

Debra Kimless, MD
Chief Medical Officer
PG Pharma
VIEW BIO

Headshot of Hunter Land

Hunter Land, PhD
VP, Research & Development
Biopharmaceutical Research Company
VIEW BIO

Headshot of Jeffrey Raber

Jeffrey Raber, PhD
Chief Executive Officer
The Werc Shop
VIEW BIO

Headshot of David Neundorfer

David Neundorfer
Chief Executive Officer

Open Book Extracts
VIEW BIO

Headshot of Loren DeFalco

Loren DeFalco
Partner
Director of Research

CB1 Capital Management
VIEW BIO

Headshot of Elena Mervine

Elena Mervine
Partner
CohnReznick Advisory - Transaction Advisory Services
VIEW BIO

Headshot of Eric Berlin

Eric Berlin
Partner
Co-Head Cannabis Group
VIEW BIO

Headshot of David Kerr

David S. Kerr
Partner and Co-Founder
Berg Hill Greenleaf Ruscitti’s Intellectual Property Practice Group
VIEW BIO

Headshot of Oliver Cruze

Oliver Kruze
Chief Executive Officer

Tikun Olam USA
VIEW BIO

Headshot of Len May

Len May, MSc.
CEO & Co-Founder

Endocanna Health, Inc.
VIEW BIO

Headshot of Lisa Rich-Milan

Lisa Rich-Milan
Chief Executive Officer

Maridose LLC
VIEW BIO

Headshot of Trevor Shewfelt

Trevor Shewfelt, BSc. Pharm, CRE
Pharmacist

Dauphin Clinic Pharmacy
VIEW BIO

Headshot of Trevor Shewfelt

Jill Ellsworth MS, RDN
Founder & CEO

Willow Industries
VIEW BIO

Headshot of Ben Boo

Ben Boo
VP of Cultivation
Vireo Health
VIEW BIO

Headshot of Bruce Mackler

Bruce F Mackler Ph.D., J.,D.
Chairman of the Board / Co-Founder
Ethicann Pharmaceuticals Inc
VIEW BIO

Headshot of Scott Thorn

Scott Thorn
Co-Founder & COO
Open Book Extracts
VIEW BIO

Headshot of Douglas Hannah

Douglas Hannah
Partner
Silverleaf Venture Partners
VIEW BIO

Headshot of David Engel

David Engel
CEO/President
Full Moon Investments

Legalization Panel Participants

Headshot of Jean Gonnell

Jean E. Smith-Gonnell
Partner
Troutman Pepper
MODERATOR
VIEW BIO

Headshot of Bryan Hanes

Bryan M. Haynes
Partner
Troutman Pepper
PANELIST
VIEW BIO

Headshot of Willie J. McKinney

Dr. Willie J. McKinney
Founder and CEO
McKinney Regulatory Science Advisors, LLC
PANELIST
VIEW BIO

Headshot of Sheri Orlowitz

Sheri Orlowitz
Founder, Chair of the Board
Council for Federal Cannabis Regulation
PANELIST
VIEW BIO

Headshot of Tucker Eldridge

Tucker Eldridge
Operations Director
Natures Herbs and Wellness
PANELIST
VIEW BIO

Legalization Panel Schedule

Sunday, May 12th, 2024 / 4:10 PM - 5:10 PM

ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.

Image